Two years ago, Deep Genomics was juggling about 40 different machine learning models to decode RNA biology. Now, they’ve revamped their approach with a single, powerful AI system known as BigRNA. This foundation model is capable of predicting how genes behave in different tissues, how they’re spliced, and how they interact with other cellular components…
Skynet with benefits: Can AI and humans become a drug discovery superorganism?
Will the credit for future mega-blockbuster drugs, in some cases, go to a carefully-programmed AI discovery system connected to a “self-driving lab” that verified its potential? Certainly, AI is hyped, but so are potential profits of potentially AI-optimized drugs. The exploding volumes of scientific data highlight a shift often overlooked: what does “inventor” even mean when…
AWS expands collaborations with Amgen and Merck to advance AI in drug discovery and manufacturing
At its annual re:Invent event, Amazon Web Services (AWS) announced expanded alliances with two leading drug developers, Amgen and Merck, to create generative artificial intelligence (AI) technologies aimed at accelerating drug discovery and increasing efficiencies in manufacturing processes. Merck has been working with AWS and Accenture for several years whereas Amgen and AWS have collaborated…